FDA Tells Drugmakers to Use Its Inspection Checklist on CMOs
The FDA is giving drugmakers some key advice for qualifying and auditing contract manufacturers: Start by requesting the same documents the agency wants to see when it begins an audit.
CBER Investigator Pam Trost said a routine audit or qualification audit should start with a request for the following information:
The company’s organizational chart;
Production floor diagrams showing room classifications;
In-process and final product specifications;
List of names and addresses of approved vendors, including testing facilities;
Lists of all lots currently quarantined besides those awaiting initial routine testing;
Outstanding complaints and adverse event reports;
Failure investigations and process deviations;
Resolved and unresolved out-of-specification results;
Sterility and environmental failures and investigations; and
Additionally, drugmakers should review the contract manufacturing organization’s standard operating procedures, quality management systems and the training and qualification of staff. “You may not get everything you ask for during an audit, but you can still ask,” Trost said.
When a contract manufacturer notices something unusual about your product — an unusual result, a change in raw materials supplier, a new piece of equipment or packaging — do they react the way you want?
Problems with a contract manufacturer or lab can emerge in dozens of unexpected places, and with FDAnews’ Managing Contract Manufacturers and Testing Labs you can have this comprehensive, step-by-step guide written by the foremost authorities in the pharmaceutical manufacturing field. Don’t wait, order your copy today.
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today.Read More
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today.Read More
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not!